Table 5 Multivariate Cox regression analysis for QoL function and symptom scales (Block Entry Method)
From: Quality of life assessment as a predictor of survival in non-small cell lung cancer
QoL Domain | HR | 95% CI | P-value |
|---|---|---|---|
Physical | 0.990 | 0.986 to 0.994 | < 0.001 |
Role | 0.999 | 0.995 to 1.002 | 0.50 |
Emotional | 1.001 | 0.997 to 1.005 | 0.58 |
Cognitive | 1.000 | 0.996 to 1.003 | 0.80 |
Social | 1.000 | 0.996 to 1.003 | 0.85 |
Fatigue | 0.996 | 0.992 to 1.001 | 0.16 |
Nausea/vomiting | 0.997 | 0.993 to 1.001 | 0.20 |
Pain | 1.002 | 0.999 to 1.005 | 0.16 |
Dyspnea | 1.001 | 0.999 to 1.004 | 0.34 |
Appetite Loss | 1.003 | 1.000 to 1.005 | 0.07 |
Constipation | 1.000 | 0.998 to 1.003 | 0.73 |
Diarrhea | 1.003 | 0.999 to 1.006 | 0.16 |
Gender (male as reference) | 0.78 | 0.67 to 0.90 | 0.001 |
Stage at diagnosis (locoregional disease as reference) | 1.67 | 1.4 to 1.9 | < 0.001 |
Prior treatment history (previously treated as reference) | 0.55 | 0.47 to 0.64 | < 0.001 |